Purchase Order 75H71022P00392
- Not listed
- This firm fixed-price purchase order was awarded by the Department of Health and Human Services Indian Health Service to Biofire Diagnostics LLC, a foreign-owned for-profit organization. The $149,038.88 contract is for a lab lease agreement and supplies, with a completion date of October 31, 2018. Biofire Diagnostics LLC is a biotech company that specializes in syndromic infectious disease testing and has received numerous federal contracts to provide a variety of related goods and services,...
- This is a Delivery Order (DO) awarded by the Indian Health Service (IHS), a civilian agency within the U.S. Department of Health and Human Services, to Biofire Diagnostics LLC. The DO is for COVID-19 testing panels and kits, and is issued under an Indefinite Delivery, Indefinite Quantity (IDIQ) contract. The total ceiling value of this order is $68,984. Biofire Diagnostics LLC is a foreign-owned, for-profit biotech company that specializes in syndromic infectious disease testing. This order does...
- This is a firm fixed-price purchase order awarded by the Indian Health Service, a civilian agency within the U.S. Department of Health and Human Services, to Biofire Diagnostics LLC for the provision of a BIOFIRE ANALYZER, KITS AND PANELS, and UNO SERVICE UNIT to support COVID-19 response efforts. The award, valued at $57,100.00, has an ultimate completion date of October 31, 2021. Biofire Diagnostics LLC is a foreign-owned, for-profit organization that specializes in syndromic infectious...
- This is a $2,474,747.75 fixed-price purchase order awarded by the Defense Health Agency to Biofire Diagnostics LLC, a foreign-owned for-profit biotech company, for the provision of testing kits and panels for Bloodstream Infections, COVID-19, Meningitis/Encephalitis, and other infectious diseases. The contract has an ultimate completion date of April 29, 2026 and does not utilize a set-aside designation. Biofire Diagnostics LLC is an experienced federal contractor, holding several indefinite...
- This federal contract award was made by the Department of Health and Human Services Indian Health Service to Biofire Diagnostics LLC, a foreign-owned for-profit biotech company that specializes in syndromic infectious disease testing. The $218,091.46 Firm Fixed Price purchase order is for CCHCF-FY2019 CH-LAB PRIORITY A CPT (BIOFIRE- IHS5419217) services to be delivered by December 31, 2019. The contract does not have a set-aside designation. Biofire Diagnostics LLC holds several indefinite...
- This is a $17,254.06 firm fixed price purchase order awarded to Biofire Diagnostics LLC, a for-profit foreign-owned biotech company, by the Bureau of Administration, a civilian federal agency. The contract is for the provision of medical supplies with no set-aside designation. Biofire Diagnostics LLC specializes in syndromic infectious disease testing and has an existing General Services Administration Federal Supply Schedule contract for in-vitro diagnostics, reagents, and tests. This award...
- The Defense Health Agency awarded a firm-fixed-price purchase order to Biofire Diagnostics LLC, a foreign-owned for-profit biotech company, to provide molecular diagnostic testing kits. The $242,760 contract has a completion date of September 30, 2022 and was not set aside for any particular business type. Biofire Diagnostics is a leader in syndromic infectious disease testing and has held numerous federal contracts to supply a range of testing products and services, including to the...
- This is a $17,254.06 firm fixed-price purchase order awarded to Biofire Diagnostics LLC, a foreign-owned for-profit organization, by the Bureau of Administration, a civilian federal agency. The contract is for the delivery of lab items for various posts, with a completion date of April 13, 2024. Biofire Diagnostics LLC is a biotech company that specializes in syndromic infectious disease testing and has received numerous federal contract awards as a prime contractor, including against its...
- This firm fixed-price purchase order was awarded by the Indian Health Service, a civilian agency, to Biofire Diagnostics LLC, a for-profit foreign-owned company, to provide a molecular biology analyzer. The $20,752.50 contract has an ultimate completion date of October 31, 2021. It was awarded on September 10, 2020 and does not have a set-aside designation. The contract was issued against Biofire Diagnostics' General Services Administration Federal Supply Schedule contract for in-vitro...
- This is a sole source contract awarded by the Indian Health Service (IHS), a civilian agency within the Department of Health and Human Services, to Biofire Diagnostics LLC, a foreign-owned for-profit organization, for cost per test and supplies. The contract has a ceiling value of $98,811.48 and was awarded on December 29, 2020 as a firm fixed price purchase order. The contract is for the lease of one FLM2-SRV-0001 instrument and associated supplies for the laboratory department at the Chinle...
This is a $286,617.93 firm fixed-price purchase order contract awarded by the U.S. Department of Health and Human Services Indian Health Service to Biofire Diagnostics LLC, a foreign-owned for-profit biotech company, for cost per test and supplies. The contract has a period of performance through July 31, 2023 and does not have a set-aside designation. Biofire Diagnostics LLC is a leader in syndromic infectious disease testing and has received numerous federal contracts and task orders to provide a variety of infectious disease testing products and services, including to the Department of Veterans Affairs and Defense Health Agency. This award appears to be part of Biofire's existing General Services Administration Federal Supply Schedule contract for in-vitro diagnostics, reagents, and tests.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00011 | Funding Only Action | ($141k) | 1/15/25 | |
| P00010 | Other Administrative Action | $0 | 6/29/23 | |
| P00009 | Funding Only Action | $15.6k | 6/8/23 | |
| P00008 | Other Administrative Action | $0 | 6/5/23 | |
| P00007 | Funding Only Action | $15.6k | 5/22/23 |